Creoptix
Edit

Creoptix

https://www.creoptix.com/
Last activity: 11.01.2022
Active
Categories: AnalyticsDrugIndustryLifeMeasurementMedTechProductResearchScienceTechnology
Modern label-free technology, no-clog microfluidics and automated software for superior affinity and kinetic data in drug discovery and research.
Mentions
18
Location: United States, Indiana, York
Employees: 11-50
Total raised: $11.3M
Founded date: 2009

Investors 6

Funding Rounds 2

DateSeriesAmountInvestors
30.09.2019Series C$8.02M-
21.11.2013Series A$3.29M-

Mentions in press and media 18

DateTitleDescription
11.01.2022Creoptix joins the Malvern Panalytical team in England
27.05.2020Swiss start-ups drive research around Covid-19Swiss start-ups are very active in the quest for therapies against Covid-19. You can find several examples in our article from 5 May. According to the weekly updated view of the Covid-19 product pipeline creates by BIO’a Industry Analysis T...
27.05.2020Swiss start-ups drive research around Covid-19
13.12.2019The New Year resolution for startups: New executive members aboard
04.10.2019Microfluidics mastery earns Switzerland’s Creoptix $8m Series CSpare a thought for agri-tech companies out there focused on microfluidics — the swiftly advancing science of handling and manipulating tiny flows of fluids measured in microliters or picoliters. It’s key for crop science, and it is already...
30.09.2019Mer­ck touts Phase III da­ta for an­tibac­te­r­i­al Re­car­brio; Sanofi to ax 200 jobs in Japan — re­port→ Ac­cord­ing to an anony­mous source who re­port­ed to Reuters, French drug­mak­er Sanofi plans to ax 200 jobs in Japan across sales, reg­u­la­to­ry af­fairs and op­er­a­tions. This adds to the on­go­ing plans of re­or­ga­ni­za­tion by re­...
30.09.2019Creoptix raises CHF8 million in Series C round
26.12.2018Zweiter Standort für Start-ups in Wädenswil
07.09.2018Creoptix attracts Waters as corporate investor
20.11.2017LeadXpro AG relies on Creoptix’s technology
Show more

Reviews 0

Sign up to leave a review

Sign up Log In